Anduril has not announced an official IPO date yet , but most credible coverage and analyst commentary point to a likely window sometime in 2026–2027 , not sooner, and it has not gone public as of early 2026.

📰 What’s the latest on “when will Anduril IPO”?

  • There is no SEC filing or confirmed IPO date on record yet.
  • Analyst writeups and private-market platforms repeatedly describe Anduril as “pre‑IPO” , with expectations that it may list within 12–24 months from early/mid‑2025.
  • Several summaries explicitly say a 2026 IPO is the “most likely” scenario , with 2027 still on the table depending on markets and execution of its big Ohio manufacturing build‑out.

So if your keyphrase is “when will Anduril IPO” , the honest answer today is: no fixed date , but the market consensus “best guess” is a listing sometime in 2026 , slipping into 2027 if conditions or operations dictate.

🔍 What are people saying on forums?

Public forum threads echo more or less the same story: rumors, not dates.

“Atm only rumors. The CEO has stated that he would like to take Anduril public by 2026 or something like that. Best I can do is save and wait.”

You’ll also see:

  • Users speculating on IPO price (often joking guesses like “20–30 per share”) with no hard data behind it.
  • Investors comparing it to Palantir as a defense/AI name they want early access to, but acknowledging they’re still stuck in secondary markets (EquityZen, Forge, etc.) until any IPO actually happens.

Overall forum discussion : hopeful, speculative, but everyone admits there’s no official timetable yet.

📈 Why 2026–2027 keeps coming up

Analyst and pre‑IPO coverage keep circling around the same drivers:

  • Massive funding and high valuation
    • Articles cite valuations around 28–30+ billion USD by 2025 after large funding rounds, which is typically the stage where a company starts to look seriously at public markets.
  • Big defense contracts and revenue momentum
    • Coverage highlights multi‑hundred‑million to multibillion‑dollar U.S. defense contracts and growing revenue, which strengthens the case for a large‑cap public listing.
  • Ohio manufacturing expansion as a “trigger”
    • Several write‑ups note that if Anduril’s Ohio manufacturing facility build‑out goes to plan, it makes a 2026 or 2027 IPO “plausible” because it proves production scale and contract execution.

One article sums it up as: no filing yet, but all indicators point to Anduril going public in the next 12–24 months, with 2026 as the strongest bet.

🧭 How to follow “when will Anduril IPO” going forward

If you’re tracking this as an investor or just a defense‑tech watcher, here’s a simple playbook:

  1. Watch for an S‑1 filing
    • The first hard signal will be an S‑1 registration statement appearing on the SEC’s site; until then everything is just guidance and rumor.
  2. Monitor official news from Anduril
    • Press releases or blog posts about “confidentially submitting” paperwork, or hiring high‑profile finance executives, often precede an IPO.
  3. Keep an eye on pre‑IPO platforms
    • Sites like Forge, EquityZen, and IPO‑watch blogs are already labeling Anduril as “upcoming IPO” and speculating on timing; they’ll typically update quickly if a date appears.

TL;DR

  • Has Anduril IPO’d yet? No.
  • Is there an official date? No.
  • Best current estimate? Commentators and pre‑IPO analysts mostly point to a 2026 IPO as “most likely,” with 2027 still possible , tied to execution of its Ohio expansion and overall market conditions.

Information gathered from public forums or data available on the internet and portrayed here.